Singapore markets closed

Straits Times Index
3,426.47
-3.98(-0.12%)
Nikkei
37,667.41
-202.10(-0.53%)
Hang Seng
17,021.31
+16.34(+0.10%)
FTSE 100
8,285.71
+99.36(+1.21%)
Bitcoin USD
68,956.81
+1,361.02(+2.01%)
CMC Crypto 200
1,391.78
+61.17(+4.60%)

Alnylam Pharmaceuticals, Inc. (0HD2.L)

LSE - LSE Delayed price. Currency in USD

Add to watchlist

233.68

-7.57

(-3.14%)

At close: 06:28PM BST

Loading interactive chart…

Zacks
Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Alnylam (ALNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Simply Wall St.
Market Sentiment Around Loss-Making Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Alnylam Pharmaceuticals, Inc. ( NASDAQ:ALNY ) is possibly approaching a major achievement in its business, so we would...
Business Wire
Alnylam to Webcast Conference Call Discussing Second Quarter 2024 Financial Results
CAMBRIDGE, Mass., July 18, 2024--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the second quarter ending June 30, 2024 on Thursday, August 1, 2024, before the U.S. financial markets open.